TfR-T12 TFA is a potent and selective inhibitor used in the biomedical industry to target the transferrin receptor (TfR) to treat iron deficiency related diseases such as anemia. This product aids in regulating iron homeostasis by blocking the binding of transferrin to the TfR, resulting in decreased iron uptake by cells.
CAT# | GR2192 |
M.F/Formula | C73H100F3N19O17S |
M.W/Mr. | 1604.75 |
Appearance | Solid |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
The cyclopentapeptide FC 131 (cyclo(-L-Arg1-L-Arg2-L-2-Nal3-Gly4-D-Tyr5-), 2-Nal=3-(2-naphthyl) alanine)) is an ...
Vasoconstrictor substances, such as norepinephrine and epinephrine, have been mingled with local anesthetics to ...
Peptide YY is referred to as PYY. Its structure is highly homologous with pancreatic polypeptide (PP) and neurop ...
BIO 1211, is a non-covalent, small-molecule, cyclohexanecarboxylic acid base compound, tight-binding inhibitor ( ...
Insulin was discovered by Banting and Best in 1921. Soon afterwards manufacturing processes were developed to extract the ins ...